Riskpilot← Back to searchSign inGet full accessSqoom Global AB
ABActiveOrg 5568785504Österlånggatan 18Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20111 employees
Revenue 2024
SEK 311K
-6% vs 2023
EBITDA margin
-94.9%
+39% vs 2023
Equity ratio
2.0%
Financial strength
Net profit 2024
SEK -342K
+29% vs 2023
| Revenue | SEK 311K | -6% |
| EBITDA | SEK -295K | +39% |
| Net profit | SEK -342K | +29% |
| Total assets | SEK 2,5M | -55% |
| Equity | SEK 50K | +101% |
| Employees | 1 | — |
Legal name
Sqoom Global AB
Org number
5568785504
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23 december 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Klereby, Rude Bertil
Company purpose
Bolaget skall bedriva handel teknisk utrustning inom medicin och skönhetsvård, import och export av medicinska- såväl som skönhetsprodukter samt därmed förenlig verksamhet.
Address
Österlånggatan 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 23 | 1 104 | 2 099 | 506 | 332 | 311 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −3 | −5 | — | — | −405 | −2 030 | −2 471 | −493 | −480 | −295 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −5 | 0 | 0 | −405 | −2 030 | −2 471 | −493 | −480 | −295 |
| Net financials | — | — | — | — | — | −75 | — | −1 | −1 | −1 809 |
| Profit before tax | −3 | −5 | 0 | 0 | 20 | −2 105 | −2 471 | −494 | −481 | −342 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −1 | −0 | −0 | −0 |
| Net profit | −3 | −5 | 0 | 0 | 20 | −2 105 | −2 472 | −494 | −481 | −342 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 126 | 22 | 7 | 22 | 868 | 3 941 | 5 416 | 5 789 | 5 654 | 2 546 |
| Equity | 26 | 22 | 27 | 22 | 42 | 37 | −2 435 | −2 929 | −3 410 | 50 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 3 583 | 7 621 | 8 580 | 8 989 | 2 416 |
| Short-term debt | 6 100 | 0 | 20 | 0 | 826 | 321 | 230 | 138 | 76 | 80 |
| Total debt | 6 100 | — | 20 | — | 826 | 3 904 | 7 851 | 8 718 | 9 065 | 2 496 |
EBITDA margin
-94.9%
This company
15.8%
Market median
-701% vs market
20152024
Equity ratio
2.0%
This company
38.2%
Market median
-95% vs market
20152024
Return on equity
-684.0%
This company
18.4%
Market median
-3817% vs market
20152024
Net profit margin
-110.0%
This company
8.1%
Market median
-1458% vs market
20152024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20152024
Debt / equity
49.92×
This company
0.62×
Market median
-7952% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ONMED Oncology Medical Devices AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDTEC CUTIS N.V.ONMED Oncology Medical Devices AB
Sqoom Global AB (this company)Sqoom TurkeySQOOM TURKEYBoard members of Sqoom Global AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Tommy Hiller | Chairman | 0 companies |
| Leif Olof Rickardsson | Deputy Board Member | 0 companies |
| Rude Bertil Klereby | Board of Directors | 0 companies |
| Kurth Stephan Jörgne | Board of Directors | 0 companies |
| Helmut Schick | Board of Directors | 0 companies |